Article
A new study has joined a host of others concluding that high-volume surgeons have better outcomes than surgeons who perform a procedure less often.
Expert discusses the promise of emerging MISTs for BPH
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
FDA Advisory Committee finds evidence for UGN-102 inconclusive, cites uncertainty in benefit-risk
2 Commerce Drive
Cranbury, NJ 08512